Vanlandschoot P - Search Results

1

The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure.

Vanlandschoot P, Cao T, Leroux-Roels G. Vanlandschoot P, et al. Antiviral Res. 2003 Oct;60(2):67-74. doi: 10.1016/j.antiviral.2003.08.011. Antiviral Res. 2003. PMID: 14638400 Review.

2

Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B.

Cao T, Desombere I, Vanlandschoot P, Sällberg M, Leroux-Roels G. Cao T, et al. Among authors: vanlandschoot p. J Gen Virol. 2002 Dec;83(Pt 12):3023-3033. doi: 10.1099/0022-1317-83-12-3023. J Gen Virol. 2002. PMID: 12466479

3

Viral apoptotic mimicry: an immune evasion strategy developed by the hepatitis B virus?

Vanlandschoot P, Leroux-Roels G. Vanlandschoot P, et al. Trends Immunol. 2003 Mar;24(3):144-7. doi: 10.1016/s1471-4906(03)00026-7. Trends Immunol. 2003. PMID: 12615210 Review.

4

The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate.

Vanlandschoot P, Van Houtte F, Serruys B, Leroux-Roels G. Vanlandschoot P, et al. J Gen Virol. 2005 Jan;86(Pt 1):75-84. doi: 10.1099/vir.0.80580-0. J Gen Virol. 2005. PMID: 15604433

5

Immunostimulatory potential of hepatitis B nucleocapsid preparations: lipopolysaccharide contamination should not be overlooked.

Vanlandschoot P, Van Houtte F, Ulrichts P, Tavernier J, Leroux-Roels G. Vanlandschoot P, et al. J Gen Virol. 2005 Feb;86(Pt 2):323-331. doi: 10.1099/vir.0.80605-0. J Gen Virol. 2005. PMID: 15659751

6

Inhibition of replication of primary HIV-1 isolates in huPBL-NOD/Scid mice by antibodies from HIV-1 infected patients.

Steyaert S, Heyndrickx L, Verhoye L, Vermoesen T, Donners H, Fransen K, Van Wanzeele F, Vandergucht B, Vanham G, Leroux-Roels G, Vanlandschoot P. Steyaert S, et al. Among authors: vanlandschoot p. Antiviral Res. 2007 Aug;75(2):129-38. doi: 10.1016/j.antiviral.2006.10.013. Epub 2007 Mar 6. Antiviral Res. 2007. PMID: 17379323

7

Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.

Cao T, Lazdina U, Desombere I, Vanlandschoot P, Milich DR, Sällberg M, Leroux-Roels G. Cao T, et al. Among authors: vanlandschoot p. J Virol. 2001 Jul;75(14):6359-66. doi: 10.1128/JVI.75.14.6359-6366.2001. J Virol. 2001. PMID: 11413302 Free PMC article.

8

Prevention of hepatitis B infections: vaccination and its limitations.

Leroux-Roels G, Cao T, De Knibber A, Meuleman P, Roobrouck A, Farhoudi A, Vanlandschoot P, Desombere I. Leroux-Roels G, et al. Among authors: vanlandschoot p. Acta Clin Belg. 2001 Jul-Aug;56(4):209-19. doi: 10.1179/acb.2001.032. Acta Clin Belg. 2001. PMID: 11603250 Review.

9

Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor.

Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Leroux-Roels G. Vanlandschoot P, et al. J Gen Virol. 2002 Jun;83(Pt 6):1281-1289. doi: 10.1099/0022-1317-83-6-1281. J Gen Virol. 2002. PMID: 12029142

10

LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles.

Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Stelter F, Peterson DL, Gomez-Gutierrez J, Gavilanes F, Leroux-Roels G. Vanlandschoot P, et al. J Gen Virol. 2002 Sep;83(Pt 9):2279-2289. doi: 10.1099/0022-1317-83-9-2279. J Gen Virol. 2002. PMID: 12185283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters